Arredondo Montero et al. (27) conducted a systematic review to evaluate the diagnostic performance of Leucine-Rich Alpha-2-Glycoprotein (LRG1) in PAA, focusing on its potential as a non-invasive biomarker. This evidence concerns the gene LRG1 and pulmonary artery-aorta diameter ratio measurement.